期刊文献+

联合激动Toll样受体的树突细胞诱导抗结肠癌免疫反应 被引量:2

Dendritic cells with synergistic activation of Toil-like receptor ligands induce antitumor effects against colon cancer in vitro
原文传递
导出
摘要 目的观察联合激动Toll样受体(TLR)能否使树突细胞(DC)达到更理想的成熟状态,并诱导出抗结肠癌免疫反应。方法在体外培养DC过程中加入TLR3和TLR7/8配体,流式细胞仪检测DC重要表型表达,酶联免疫吸附实验(ELISA)法检测白细胞介素(IL)-12分泌量,3H—thymidine掺人法检测DC促淋巴细胞增殖能力,使用CEA转基因鼠和转染CEA的MC38小鼠结肠癌细胞株(MC38-CEA)构建动物模型,乳酸脱氢酶(LDH)释放法检测DC诱导细胞毒性T淋巴细胞(CTL)对MC38-CEA的体外杀伤作用。结果联合激动TLR的DC与常规组比较,能高水平表达DC重要表型,分泌更多IL-12(P〈0.01),更有效刺激淋巴细胞增殖(P〈0.01),荷载抗原后诱导的效应细胞在效靶比为20:1和40:1时,对MC38-CEA的杀伤率为(31.9±3.3)%和(39.1±4.2)%,而其他各组无明显杀伤作用(P〈0.05)。结论联合激动TLR的DC具有更理想的成熟度,能诱导更有效的抗肠癌免疫反应,提示联合激动TLR可能是增强DC肿瘤疫苗疗效的有效途径。 Objective To investigate the immune functions of DCs with synergistic activation of TLR ligands and the antitumor effects against colon cancer induced by DCs in vitro. Methods We involved combination of TLR ligands in culture protocol of DCs. The DCs' important surface molecules expression was detected by flow cytometry. DCs'IL-12 secretion was evaluated by ELISA and the proliferating capacity of lymphocytes was tested by 3 H-thymidine assay. The CEA transgenic mice and MC38-CEA mouse colon cancer cell line were employed as animal model and the CTL activity against MC38-CEA induced by pulsed DCs was tested by LDH cytotoxicity assay. Results Compared with conventional generated DCs, DCs combined with activation of TLR showed higher surface molecules expression ,significantly higher secretion of IL-12 and more potent proliferating capacity of lymphocytes as well. The cytolytic activity against MC38-CEA cells shown by effector cells induced by pulsed DCs with combined activation of TLR was (31.9 ±3.3 )% and (39.1 ±4. 2)% when the E: T ratio was 20:1 and 40:1 respectively, but no obvious cytolytic activity was found showed in other groups. Conclusion DCs combined with activation of TLR showed better maturation status and can also induce more effective antitumor immune effects against colon cancer, suggesting combined activation of TLR may be the effective strategy for developing more powerful DCs cancer vaccines.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第3期353-355,共3页 Chinese Journal of Experimental Surgery
关键词 结肠肿瘤 树突细胞 TOLL样受体 癌胚抗原 Colonic neoplasms Dendritic cells Toll-Like receptors Carcinoembryonic antigen
  • 相关文献

参考文献9

  • 1Banchereau J,Palucka AK.Dendritic ceils as therapeutic vaccines against cancer.Nat Rev Immunol,2005,5:296-306.
  • 2Clarke P,Mann J,Simpson JF,et al.Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy.Cancer Res,1998,58:1469-1477.
  • 3Schmitz J,Reali E,Hodge JW,et al.Identification of an interferongamma-inducible carcinoembryonic antigen(CEA)CD8(+)T-cell epitope,which mediates tumor killing in CEA transgenic mice.Cancer Res,2002,62:5058-5064.
  • 4Inaba K,Inaba M,Romani N,et al.Generation of large numbers of dendritic cells from monse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.J Exp Med,1992,176:1693-1702.
  • 5Warger T,Osterloh P,Rechtsteiner G,et al.Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo.Blood,2006,108:544-550.
  • 6安岗,毛伟征,代震波,牛兆建,刘希春,解西河,赵宝成.抗原致敏树突细胞增强细胞因子诱导杀伤细胞抗胃癌的效应[J].中华实验外科杂志,2008,25(4):422-424. 被引量:5
  • 7李东印,闵军,褚忠华,谷川,区庆嘉.抗原负载的树突状细胞体外诱导抗肿瘤免疫的研究[J].中华实验外科杂志,2008,25(9):1146-1148. 被引量:5
  • 8Iwasaki A,Medzhitov R.Toll-like receptor control of the adaptive immune responses.Nat Immunol,2004,5:987-595.
  • 9Napolitani G,Rinaldi A,Bertoni F,et al.Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.Nat Immunol,2005,6:769-776.

二级参考文献12

  • 1湛海伦,高新,邱剑光,蔡育彬,司徒杰.树突状细胞与细胞因子诱导杀伤细胞共培养体外抗肾癌的效应[J].中华实验外科杂志,2005,22(9):1144-1144. 被引量:10
  • 2陈炬,华平,张强,彭江洲,黎亮,杨艳旗.肺癌抗原负载的树突细胞体外诱导细胞毒性T淋巴细胞的杀瘤作用[J].中华实验外科杂志,2006,23(11):1337-1339. 被引量:9
  • 3代震波,毛伟征,牛兆建,曹永献,隋爱华,刘希春,吕振华.体外扩增CIK细胞杀伤胃癌细胞SGC-7901[J].中华肿瘤防治杂志,2007,14(2):100-103. 被引量:15
  • 4Zhang S, Wang Q, Li WF, et al. Enhanced antitumor immunity by murine cytokine activated T lymphocytes after cocultured with bone marrow derived dendritic cells pulsed with whole tumor lysates. Leukemia Research ,2004,28 : 1085-1088.
  • 5Erhardt M, Schmidt-wolf IG, Sievers E,et al. Anti-tumor capabilities of effector cells after IFN-alpha or CpG-motif treatment of cocultured dendritic cells. Arch Immunol Ther Exp (warsz) ,2006,54:403-409.
  • 6Wongkajomsilp, Sangsuriyong S, Hongeng S, et al. Effective osteosarcoma cytolysis using cytokine-induced killer cells pre-inoculated with tumor RNA-pulsed dendritic cells. J Orthop Res, 2005, 23 : 1460- 1466.
  • 7Lanzavecchia A ,Sallusto F. Regulation of T cell immunity by dendritic cells. Cell,2001,106:263 -266.
  • 8Morse MA , Mosca PJ , Clay TM, et al. Dendritic cell maturation in active immunotherapy strategies. Expert Opin Biol Ther , 2002 , 2 : 35- 43.
  • 9Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte macrophage colony - stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med, 1994,179 : 1109 -1118.
  • 10Schueller G, Stift A, Friedl J, et al. Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to coculture with tumor lysate pulsed dendritic cells. Int J Oncol,2003,22 : 1397-1402.

共引文献8

同被引文献29

  • 1Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines a- gainst cancer. Nat Rev Immunol,2005 ,5 :296-306.
  • 2Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer,2009,9:57-63.
  • 3Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in in- nate immune defence. Nat Rev Immunol,2007 ,7 :179-190.
  • 4Whitmore MM, Deveer MJ, Edling A, et al. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res,2004,64:5850-5860.
  • 5Clarke P, Mann J, Simpson JF, et al. Mice transgenic for human carci- noembryonic antigen as a model for immunotherapy. Cancer Res, 1995,58:1469-1477.
  • 6Warger T, Osterloh P, Rechtsteiner G, et al. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superi- or CTL responses in vivo. Blood,2006,108:544-550.
  • 7Ojima T, Iwahashi M, Nakamura M, et al. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA) -expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice. Int J Cancer,2007, 120:585-593.
  • 8Boullart AC, Aarntzen EH, Verdijk P, et al. Maturation of monocyte- derived dendritic cells with Toll-like receptor 3 and 7/8 ligands com- bined with prostaglandin E2 results in high interleukin-12 production and cell migration. Cancer Immunol Immunother, 2008, 57: 1589- 1597.
  • 9Conroy H,Marshall NA, Mills KH. TLR ligand suppression or enhance- ment of Treg cells? A double-edged sword in immunity to tumours. Onco- gene,2008,27 : 168-180.
  • 10Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family [J]. Nat Immunol, 2010, 11(3): 197-206.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部